Abstract
When proceeding with hormone therapy or gender affirming surgery, transgender patients should have the option of undergoing fertility preservation [1]. Prior to assisted reproductive technology, transgender men have traditionally had to discontinue exogenous testosterone for up to 6 months or until resumption of menses [2]. The process and experience associated with stopping testosterone has proven to be distressing for patients [3]. This report explores the feasibility of proceeding with fertility preservation in a transgender man without an extended period of androgen cessation and without the resumption of menstruation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
